Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Pregnancy's hidden warning sign: gestational diabetes doesn't end at delivery. A study of over 1 million US women found that gestational diabetes (GDM) is linked to a tenfold increased risk of type 2 diabetes and significantly elevated risks for hypertension, hyperlipidemia, obesity, and cardiovascular disease — all emerging within just a few years postpartum. Experts say the postpartum visit needs a full cardiometabolic workup, not just a glucose check.
Pregnancy's hidden warning sign: gestational diabetes doesn't end at delivery
A large study published in Obstetrics & Gynecology analyzed data from over 1.15 million commercially insured US women and found that gestational diabetes (GDM) dramatically raises the risk of multiple cardiometabolic conditions — not just type 2 diabetes (T2D) — within just a few years after delivery. Researchers followed participants for a median of 2.4 years postpartum, finding that risks for hypertension, hyperlipidemia, obesity, and cardiovascular disease were already elevated in the same window when clinicians typically screen for glucose.
What surprised researchers most wasn't the T2D risk — it was how quickly other conditions appeared in women who had no prior history of these disorders before delivery. The excess T2D risk also persisted, remaining more than sixfold higher even at 5–10 years postpartum.
By the Numbers
Why it matters: Experts are calling for postpartum visits to become full cardiometabolic assessments — covering blood pressure, lipids, and weight alongside glucose. With fewer than half of GDM patients returning for recommended postpartum glucose testing, the handoff from obstetrics to primary care is a critical gap that puts millions of women at long-term risk.
